We would like to present to you the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology. In the Hellenic Society of Medical Oncology we want FCO to serve as a forum, for us all, to communicate clinical and research achievements in English; to share thoughts, opinions, facts, problems and solutions. We envision the journal to be the means, by which our efforts in the fight against cancer will become known to a wider audience, thus establishing our presence in the global setting. FCO publishes original and translational research articles relevant to diagnosis and treatment of cancer, state-of-the-art reviews, case reports, research articles, statements of opinion and comments, all related to clinical practice and basic research. A large number of eminent Greek and Foreign colleagues who participate in the National and International Editorial Boards, with their continuum direction and support, guarantee the high quality of the work published in FCO. In every issue published there will be something new, enjoyable and exciting to be read.
We would like to welcome you to the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology. In the Hellenic Society of Medical Oncology we share the view that there are many issues we deal with in our everyday clinical and research practice that are common to our colleagues geographically closer to us, in the Balkans and the Mediterranean basin, but also to those in other parts of the world. That led us to dare "the great leap forward": to broaden the scope of our Greek scientific journal for oncology, published in Greek for the last 10 years, and develop Forum of Clinical Oncology a web based open access journal in English.
FCO will serve as a forum for us all to communicate clinical and research achievements. One of the innovations of the journal is its online management from submission of an article to its publication. Online is more efficient: submitting, reviewing, proofreading, filing and indexing. However, the most important benefit of all is easy universal access.
English has become the common language amongst scientists from around the globe. This is the reason why we chose English as the official language of the journal. Many Greek colleagues have already published work in English in distinguished journals or have studied or worked abroad. We believe that the language change will not be an impediment for our Greek colleagues to present their work in FCO, whereas on the other hand it will allow our colleagues from other countries to participate.
The Forum of Clinical Oncology publishes original and translational research articles relevant to diagnosis and treatment of cancer, state-of-the-art reviews, case reports, research articles, statements of opinion and comments, all related to clinical practice and basic research.
We share the view that there should be no barriers to knowledge and thus, we decided Forum of Clinical Oncology to be an open-access journal, i.e., any work submitted to the journal and accepted for publication shall be made immediately available to the scientific community and the general public, via the journal's website and printed version. Authors are requested to adjust accordingly the information regarding their work they wish to make public. It is the desire of the editorial team to make this journal an interactive educational tool to acquire knowledge and it is addressed to scientists working with oncology.
Please join us in our effort and submit your work to the FCO.
Similarity Check Plagiarism Screening System
The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.
Advisory Editorial Board Rene Adam, Paul Brousse Hospital, France Athanassios Argiris, University of Pittsburgh School of Medicine, United States Vassileios Avramis, Children's Hospital Los Angeles, United States Lodovico Balducci, Lee Moffitt Cancer Center and Research Institute, United States George Peter Canellos, Harvard Medical School, United States J.Y. Douillard, Medical Oncology Branch, Centre R. Gauducheau, France George Demetri, Dana-Farber Cancer Institute, United States Spyros Linardopoulos, Cancer Research UK Centre for Cancer Therapeutics, Chester Beatty Laboratories, United Kingdom Terry Mamounas, Cancer Center, Aultman Health Foundation, United States Anthony Maraveyas, Castle Hill Hospital, United Kingdom Vassiliki Papadimitrakopoulou, UT/MD Anderson Cancer Center, United States George Pavlakis, NCI at Frederick, United States Spyros Retsas, Cromwell Hospital, United Kingdom Philippe Rougier, Department of Gastroenterology, Hospital Ambroise Paris, France Giorgio Scaglioti, University of Torino, San Luigi Hospital, Italy T.C. Theoharides, Tufts University School of Medicine, Tufts Medical Center, United States
Editors Athanassios Anagnostopoulos, Henry Dunant Hospital, Greece Gerasimos Aravantinos, "Agioi Anargyroi" Hospital, Greece Athanassios Athanassiadis, General Hospital of Larissa "Koutlimpaneio & Triantafylleio", Greece Dimitrios Bafaloukos, Metropolitan Hospital, Greece Aristotelis Bamias, University General Hospital of Athens "Alexandra", Greece Ioannis Boukovinas, Theageneio Anticancer Hospital, Greece Christos Emmanouilides, Interbalkan Medical Center, Greece Helen Gogas, University General Hospital of Athens "Laiko", Greece Stylianos Kakolyris, University General Hospital of Alexandroupoli, Greece Athanasios Karampeazis, 401 General Military Hospital of Athens, Greece Michael Karamouzis, Medical School, University of Athens, Greece Ourania Katopodi, Bioclinic of Athens, Greece Georgios Klouvas, Metropolitan Hospital, Greece Christos Kosmas, General Anticancer Hospital "Metaxa", Greece Georgios Koumakis, "Agios Savvas" Anticancer Hospital, Greece Thomas Makatsoris, University General Hospital of Patra - Rio, Greece Dimitris Mavroudis, University General Hospital of Heraklion, Greece Michael Nikolaou, "Ippokrateion" University Hospital of Athens, Greece Christos Panopoulos, "Agios Savvas" Anticancer Hospital, Greece Christos Papadimitriou, University General Hospital of Athens "Alexandra", Greece Christos Papandreou, University General Hospital of Larissa, Greece Konstantinos Papazissis, Theageneio Anticancer Hospital, Greece Dimitrios Pectasides, General Hospital of Athens "Ippokratio", Greece Georgios Pentheroudakis, University General Hospital of Ioannina, Greece Amanda Psyrri, University General Hospital of Athens "Attikon", Greece Evangelia Razis, Hygeia Hospital, Greece Georgios Samonis, University General Hospital of Heraklion, Greece Ioannis Souglakos, University General Hospital of Heraklion, Greece Kyriakos Souliotis, Associate Professor, University of Peloponnese, Greece Kostas Syrigos, "Sotiria" Regional Chest Diseases Hospital of Athens, Greece Dimitrios Tryfonopoulos, "Agios Savvas" Anticancer Hospital, Greece Lambros Vamvakas, University General Hospital of Heraklion, Greece Michael Vaslamatzis, General Hospital of Athens "Evaggelismos", Greece Spyridon Xynogalos, General Hospital of Athens "Evaggelismos", Greece Nikolaos Ziras, General Anticancer Hospital "Metaxa", Greece
Section Editors Genetics Koulis Giannoukakos, NSCR Demokritos, Greece Emmanouil Saloustros, General Hospital of Heraklion "Venizeleio- Pananeio", Greece
Medical Oncology Charalambos Andreadis, Theageneio Anticancer Hospital, Greece Dimitrios Mavroudis, University of Crete, Greece Evaggelos Briasoulis, University of Ioannina, Greece
Molecular Biology Sam Murray, Genekor SA, Greece Vasiliki Kotoula, University of Thessaloniki, Greece